OMX Stockholm 30
|
2 741,08
|
-14,36
|
-0,52 %
|
Analysen zu OMX Stockholm 30-Werten
| 12.09.25 | ABB Sell | Deutsche Bank AG | |
| 09.09.25 | ABB Neutral | JP Morgan Chase & Co. | |
| 09.09.25 | Nordea Bank Abp Registered Shs Underweight | JP Morgan Chase & Co. | |
| 08.09.25 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 08.09.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 08.09.25 | Volvo AB Neutral | Goldman Sachs Group Inc. | |
| 03.09.25 | Hennes & Mauritz AB Hold | Deutsche Bank AG | |
| 02.09.25 | Hennes & Mauritz AB Neutral | UBS AG | |
| 02.09.25 | Volvo AB Outperform | RBC Capital Markets | |
| 02.09.25 | ABB Sector Perform | RBC Capital Markets | |
| 01.09.25 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.09.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 01.09.25 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 01.09.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 29.08.25 | ABB Neutral | JP Morgan Chase & Co. | |
| 27.08.25 | Volvo AB Buy | Jefferies & Company Inc. | |
| 27.08.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 27.08.25 | Nordea Bank Abp Registered Shs Buy | Goldman Sachs Group Inc. | |
| 25.08.25 | Volvo AB Buy | Jefferies & Company Inc. | |
| 21.08.25 | Nordea Bank Abp Registered Shs Underweight | Barclays Capital | |
| 20.08.25 | Volvo AB Buy | UBS AG | |
| 19.08.25 | ABB Sector Perform | RBC Capital Markets | |
| 19.08.25 | Volvo AB Outperform | RBC Capital Markets | |
| 19.08.25 | Hennes & Mauritz AB Equal Weight | Barclays Capital | |
| 18.08.25 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
| 14.08.25 | Volvo AB Overweight | JP Morgan Chase & Co. | |
| 08.08.25 | Hennes & Mauritz AB Hold | Jefferies & Company Inc. | |
| 05.08.25 | AstraZeneca Buy | UBS AG | |
| 04.08.25 | AstraZeneca Outperform | Bernstein Research | |
| 01.08.25 | AstraZeneca Outperform | Bernstein Research | |
| 01.08.25 | Hennes & Mauritz AB Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 31.07.25 | ABB Neutral | UBS AG | |
| 30.07.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 29.07.25 | AstraZeneca Outperform | Bernstein Research | |
| 29.07.25 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 29.07.25 | AstraZeneca Buy | UBS AG | |
| 29.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.07.25 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 28.07.25 | AstraZeneca Outperform | Bernstein Research | |
| 24.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.